These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Bonventre PF, Heeg H, Cullen C, Lian CJ. Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600 [Abstract] [Full Text] [Related]
9. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. Lee PK, Schlievert PM. J Clin Microbiol; 1989 Aug; 27(8):1890-2. PubMed ID: 2504778 [Abstract] [Full Text] [Related]
13. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig. Saha B, Jaklic B, Harlan DM, Gray GS, June CH, Abe R. J Immunol; 1996 Nov 01; 157(9):3869-75. PubMed ID: 8892617 [Abstract] [Full Text] [Related]
15. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection. Sharma H, Turner CE, Siggins MK, El-Bahrawy M, Pichon B, Kearns A, Sriskandan S. mSphere; 2019 Oct 09; 4(5):. PubMed ID: 31597722 [Abstract] [Full Text] [Related]
20. Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Schlievert PM, Gocke JE, Deringer JR. Clin Infect Dis; 1993 Jul 09; 17(1):26-31. PubMed ID: 8353243 [Abstract] [Full Text] [Related] Page: [Next] [New Search]